Common challenges with reimbursement in Japan include lengthy approval timelines, stringent evidence requirements, navigating complex regulatory & reimbursement processes, & obtaining premium pricing for innovative devices. Aligning with NHI standards, addressing cost-effectiveness concerns, & adapting to periodic fee schedule revisions can also pose difficulties for manufacturers entering Japan’s healthcare market.
